VSV
Vesicular Stomatitis Virus
Vesicular stomatitis virus (VSV), which belongs to the Vesiculovirus genus of the family Rhabdoviridae, is a well studied livestock pathogen and prototypic non-segmented, negative-sense RNA virus. Although VSV is responsible for causing economically significant outbreaks of vesicular stomatitis in cattle, horses, and swine, the virus also represents a valuable research tool for molecular biologists and virologists. Many properties of VSV make it a valuable tool for molecular virology research—such as its ability to express heterologous glycoproteins and replicate to high titers—also make it an excellent vaccine platform. In addition, the apparent seroprevalence of VSV antibodies is generally low within the human population, so there is little pre-existing immunity to the vector, and because the VSV replication cycle takes place exclusively in the cytoplasm of host cells, there is no potential for viral sequences to integrate into the host genome. As a result, recombinant VSV has emerged as a viable vaccine vector, and many recombinant VSV-based vaccines have demonstrated safety and immunogenicity in multiple pre-clinical and clinical trials.
All Product Categories
-
VSV Related Products (24)
Related Products (24)
- 1
- 2
-
2-Fluoroneplanocin A
0 ImagesCat. No.: HY-188062CAS No.: 138751-31-22-Fluoroneplanocin A is an Antiviral agent. 2-Fluoroneplanocin A inhibits rabbit Adenosylhomocysteine hydrolase with an IC50 of 0.20 μg/mL. 2-Fluoroneplanocin A exhibits antiviral activity against vaccinia virus, vesicular stomatitis virus, parainfluenza virus, reovirus, Junín virus, Tacaribe virus, cytomegalovirus, measles virus, mumps virus, and thymidine kinase-deficient varicella-zoster virus; it shows no antiviral activity against herpes simplex virus, coxsackievirus B4, poliovirus type 1, Semliki Forest virus, or HIV at subtoxic concentrations. 2-Fluoroneplanocin A can be used in research related to vaccinia virus infection, vesicular stomatitis virus infection, parainfluenza virus infection, reovirus infection, Junín virus infection, Tacaribe virus infection, human cytomegalovirus infection, measles virus infection, mumps virus infection, and varicella-zoster virus infection. -
loading...Please select quantityGet Quote
August 31
-
Please select quantity
August 31
Get Quote
loading... -
-
3-Deazahomoneplanocin A
0 ImagesCat. No.: HY-188063CAS No.: 161128-65-0 -
loading...Please select quantityGet Quote
August 31
-
Please select quantity
August 31
Get Quote
loading... -
-
UNC0638 hydrate
0 ImagesCat. No.: HY-110093CAS No.: 1255517-77-1UNC0638 hydrate selectively inhibits G9a and GLP histone methyltransferases with IC50 of 15 nM and 19 nM, respectively. UNC0638 hydrate inhibits TNBC cell invasion and migration in vitro. UNC0638 hydrate is also an inhibitor of EHMT1/2 and induces fetal hemoglobin (HbF) expression in human erythroid progenitor cell culture. In addition, UNC0638 hydrate has anti-FMDV (foot-and-mouth disease virus) and anti-VSV (vesicular stomatitis virus) activities, with excellent potency and selectivity against multiple epigenetic and non-epigenetic targets. -
loading...Please select quantityGet Quote
August 31
-
Please select quantity
August 31
Get Quote
loading... -
-
SMU-V18
0 ImagesCat. No.: HY-175769SMU-V18 is a vesicular stomatitis virus (VSV) inhibitor, with an EC50 of 6.2 μM. SMU-V18 inhibits VSV-GFP fluorescence intensity, viral mRNA/protein expression, and progeny virus replication. SMU-V18 interferes with early viral infection stages, also effective against wild-type VSV (VSV-WT). SMU-V18 inhibits VSV-GFP in mouse tissues and prolongs survival. SMU-V18 can be used for the study of vesicular stomatitis virus (VSV) infection. -
loading...Please select quantityGet Quote
August 31
-
Please select quantity
August 31
Get Quote
loading... -
- 1
- 2